THREE-DIMENSIONAL MODEL OF METASTATIC TUMOR ANGIOGENESIS IN RESPONSE TO ANTI-ANGIOGENIC FACTOR ANGIOSTATIN

被引:4
|
作者
Zhao, Gaiping [1 ]
Chen, Eryun [2 ]
Yu, Xiaoli [3 ]
Cui, Haipo [1 ]
Lv, Jie [1 ]
Wu, Jie [4 ]
机构
[1] Univ Shanghai Sci & Technol, Sch Med Instrument & Food Engn, Shanghai 200093, Peoples R China
[2] Univ Shanghai Sci & Technol, Sch Energy & Power Engn, Shanghai 200093, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai 200240, Peoples R China
基金
中国国家自然科学基金;
关键词
Metastatic tumor; angiogenesis; effect of angiostatin; 3D mathematical model; MATHEMATICAL-MODEL; VASCULAR NETWORKS; STRATEGIES; SIMULATION; INHIBITOR; CARCINOMA; FLOW;
D O I
10.1142/S0219519417500944
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Surgeons observed that primary tumors are capable of suppressing the growth of their metastases by generating anti-angiogenic factor angiostatin. A three-dimensional (3D) mathematical model of development of the metastatic tumor vasculature is presented to simulate the morphology and construction of 3D microvascular networks under the inhibitory effect of antiangiogenic factor angiostatin excreted by the primary tumor. The simulation results demonstrate that metastatic tumor microvascular density (MVD) decreases by about 60%, 58% and 52%, respectively, at t = 3, 7 and 14 days under the effect of anti-angiogenic factor angiostatin. The abnormal geometric and morphological features of 3D microvasculature networks inside and outside the metastatic tumor improve in the presence of angiostatin. The present model may allow to simulate experimental tests and may provide theoretical models for clinical research of anti-angiogenic therapy strategies.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] In vivo model for human tumor angiogenesis in leukemia/lymphoma or multiple myeloma and the tumor regression by anti-angiogenic gene therapy.
    Yamada, T
    Kondoh, K
    Hashiguchi, A
    Du, WL
    Hozumi, N
    Suda, T
    Sakamoto, M
    Hata, J
    BLOOD, 2002, 100 (11) : 562A - 562A
  • [42] Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model
    Brave, Sandra R.
    Eberlein, Cath
    Shibuya, Masabumi
    Wedge, Stephen R.
    Barry, Simon T.
    ANGIOGENESIS, 2010, 13 (04) : 337 - 347
  • [43] Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model
    Sandra R. Brave
    Cath Eberlein
    Masabumi Shibuya
    Stephen R. Wedge
    Simon T. Barry
    Angiogenesis, 2010, 13 : 337 - 347
  • [44] The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment
    Li, Ding
    Finley, Stacey D.
    INTEGRATIVE BIOLOGY, 2018, 10 (04) : 253 - 269
  • [45] Determining Response to Anti-Angiogenic Therapies with Monte Carlo Tumor Modeling
    Valentinuzzi, D.
    Simoncic, U.
    Titz, B.
    Jeraj, R.
    MEDICAL PHYSICS, 2014, 41 (06) : 435 - +
  • [46] Numerical simulation of tumor angiogenesis under the effect of Endostatin:considering mechanical environment in matrix and inhibiting effect of anti-angiogenic factor
    Kalkabay Gulnar
    M.W.Collins
    医用生物力学, 2009, 24 (S1) : 95 - 95
  • [47] Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis
    Yang, Guang-Wei
    Jiang, Jin-Song
    Lu, Wei-Qin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10): : 24011 - 24031
  • [48] Numerical simulation of tumor angiogenesis under the effect of Endostatin:considering mechanical environment in matrix and inhibiting effect of anti-angiogenic factor
    Kalkabay Gulnar
    MWCollins
    医用生物力学, 2009, 24(S1) (S1) : 95
  • [50] Modeling the Interplay Between Pathological Angiogenesis and Solid Tumor Growth: the Anti-angiogenic Treatment Effect
    Argyri, Katerina D.
    Dionysiou, Dimitra D.
    Stamatakos, Georgios S.
    PROCEEDINGS OF THE 2012 5TH INTERNATIONAL ADVANCED RESEARCH WORKSHOP ON IN SILICO ONCOLOGY AND CANCER INVESTIGATION - THE TUMOR PROJECT WORKSHOP (IARWISOCI), 2012,